What Bonafide Health does

Bonafide Health is a US-based women's healthcare company that develops, manufactures, and sells clinically studied, hormone-free supplements and a Class II medical device targeting menopause and perimenopause symptoms. Founded in 2011 and headquartered in Harrison, New York, the company was acquired by Pharmavite LLC — itself a portfolio company of Japan's Otsuka Pharmaceutical — in November 2023 for $425 million, providing it with capital, manufacturing scale, and retail distribution leverage. Bonafide's product portfolio is anchored by Revaree (an FDA-cleared hyaluronic acid vaginal insert for vaginal dryness, ranked #1 by gynecologists in a 2026 survey of 600 physicians), Thermella (a patented NKB-blocking supplement for hot flashes and night sweats, protected under US Patent 11,779,627), Clairvee (an acid-resistant delayed-release probiotic), Ristela (sexual satisfaction), Serenol (mood relief), Noctera (a February 2026 sleep supplement targeting GABAergic and glutamate pathways), and the Silvessa System (hair and skin). The portfolio is protected by 12+ US patents and supported by 40+ clinical studies.

Bonafide operates a multi-channel go-to-market. The primary channel is direct-to-consumer e-commerce through hellobonafide.com, with subscription pricing offering 20–50% discounts versus one-time purchase and free shipping on subscription orders. In September 2025 the company expanded into mainstream retail through Target (1,800+ stores and Target.com), and supplements this with Amazon marketplace distribution. Products are also HSA/FSA eligible through a Truemed partnership, reducing consumer out-of-pocket cost by approximately 30%. Subscription tiers range from roughly $29 to $77 per month across the product line.

The company's customer base is entirely consumer — women experiencing menopause, perimenopause, and PMS symptoms — with 1.5M+ lifetime customers and endorsement from 13,000+ physicians. Marketing is built around clinical evidence, healthcare-professional recommendations, content marketing via a Resource Center blog, social channels (Instagram, Facebook, TikTok, YouTube, Pinterest), and PR placements in outlets including the New York Times, Good Morning America, Allure, and Memorial Sloan Kettering. The company is privately held and operates under the Pharmavite / Otsuka corporate umbrella, with no public revenue disclosures available.

Name

Bonafide Health

Legal name

Bonafide Health, LLC

Website

https://hellobonafide.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

101–250 employees

Short description

Bonafide Health is a US women's healthcare company that develops and sells clinically studied, hormone-free supplements and an FDA-cleared vaginal insert for menopause and perimenopause symptoms. It sells through DTC subscriptions, Target retail, and Amazon.

Ownership category

akta.pro rank

Product category

Women's Health & Menopause Nutraceuticals

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Vaginal Moisturizers & Lubricants (CRABAIAI)

akta.pro secondary industries

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Sleep, Stress & Mood Support (HLAIADAG)

Keywords

• Women's health supplements
• Menopause symptom relief
• Hormone-free therapeutics
• Nutraceutical products
• Vaginal health care

Headquarters

HQ city

Harrison

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure

Revenue model

1. Direct-to-Consumer Product Sales: Primary revenue stream through the company's e-commerce website with subscription model offering 20-50% discounts on monthly plans. One-time purchases also available at higher price points. Subscription customers receive free shipping.
2. Retail Distribution: Products sold through Target retail stores (1,800+ locations) and Target.com as part of retail expansion strategy under parent company Pharmavite.
3. Marketplace Sales: Products available on Amazon marketplace, particularly for Noctera launch and other supplements.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Bonafide Health develops, manufactures, and sells clinically studied, hormone-free dietary supplements and a Class II medical device (hyaluronic acid vaginal insert) addressing perimenopause and menopause symptoms including vaginal dryness, hot flashes, night sweats, sleep disruption, mood swings, low sexual arousal, and estrogen-related hair and skin changes. Products are sold primarily through the company's DTC e-commerce site with a subscription model, plus Target retail and Amazon, with strong physician endorsement positioning.

Product overview

Bonafide Health is a women's healthcare company offering a portfolio of clinically studied, hormone-free supplements for menopause symptoms and women's health issues. The product lineup centers on five core symptom-relief products: Revaree/Revaree Plus (hyaluronic acid vaginal inserts for dryness), Noctera (sleep support), Thermella (hot flash relief), Clairvee Probiotic (vaginal microbiome balance), Ristela/Ristela Mixes (sexual satisfaction), and Serenol (mood swing relief). The company also offers the Silvessa System (oral capsule, hair serum, and skin serum) for estrogen-decline-related hair and skin changes, plus general wellness products (Multi Vitamin, Gut Probiotic). Products are available via direct-to-consumer subscription through the company website and Amazon, with retail expansion into Target stores. The company emphasizes clinically validated, hormone-free formulations and reports being trusted by 13,000+ doctors.

Differentiator

Problem solved

Functional benefit

Brands

• Revaree: Hyaluronic acid vaginal insert for vaginal dryness relief
• Noctera
• Thermella
• Clairvee
• Ristela
• Serenol
• Silvessa
• Relizen

Products and services

• Revaree

Quantifiable outcome

• 91% of women experienced symptom improvement with Revaree (vaginal dryness)
• +10 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered flagship and core.

• TargetflagshipChannel Partner/ Reseller/ Distributor · 1 September 2025Bonafide launched four women's health products in over 1,800 Target stores and Target.com, marking the company's first major retail expansion. Products include hormone-free solutions for menopause symptoms.
• TruemedcoreGTM or Marketing PartnerTruemed partnership enables Bonafide customers to purchase products using HSA/FSA funds. Customers complete a brief health survey, and upon approval receive a Letter of Medical Necessity for reimbursement or direct purchase with HSA/FSA cards.
• Dr. Alyssa Dweck, MS, MD, FACOG, MSCPcoreStrategic or Co-development PartnerDr. Alyssa Dweck serves as Chief Medical Officer of Bonafide Health. She conducts satellite media tours and educational initiatives about menopause and perimenopause symptoms and solutions.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Estroven: Estroven is a long-standing, mass-market menopause supplement brand (owned by i-Health) selling non-prescription products targeting hot flashes, night sweats, and hormonal balance. Directly comparable to Bonafide in category, target customer (women in perimenopause/menopause), and OTC distribution model.
• Pause: Pause is a venture-backed DTC women's wellness brand focused on menopause symptoms (hot flashes, sleep, mood, libido). Highly comparable to Bonafide as a digitally native, science-led menopause brand targeting the same primary demographic with subscription-based products.
• Amberen: Amberen is a menopause supplement brand offering non-hormonal capsules for hot flashes, night sweats, mood, and sleep. Directly overlaps with Bonafide in mechanism (non-hormonal), indication (menopause symptom relief), and channel (DTC plus mass-market retail).
• Replens: Replens is a leading over-the-counter vaginal moisturizer brand (Church & Dwight) using bioadhesive/hydrating technology for vaginal dryness. Directly comparable to Bonafide's Revaree and Revaree Plus hyaluronic acid vaginal inserts, addressing the same indication in the same demographic.
• Hyalo-Gyn: Hyalo-Gyn is a hyaluronic acid-based vaginal moisturizer sold OTC for vaginal dryness and intimate comfort. A direct, single-product competitor to Revaree in the hyaluronic acid vaginal insert category Bonafide has been ranked #1 in by gynecologists.
• Equelle: Equelle is an OTC menopause supplement brand built around S-equol for hot flashes and other menopausal symptoms. Directly comparable to Bonafide's Thermella in mechanism (non-hormonal supplement targeting menopausal relief) and target consumer.

Broad incumbents

• Ritual: Ritual is a digitally native vitamins and supplements brand with a women's health focus and subscription model. Comparable to Bonafide in DTC/subscription GTM, premium positioning, and clean-label supplement ethos, though not menopause-specialized.
• Care/of: Care/of is a personalized DTC vitamin and supplement subscription brand. Comparable to Bonafide in subscription-based DTC supplement business model and target demographics (women's health/wellness), though it is broader across nutritional supplements rather than menopause-specialized.
• Metagenics: Metagenics is a practitioner-grade nutritional supplement company with a women's health portfolio including menopause-targeted products. Comparable to Bonafide in clinically studied nutraceuticals and physician-channel marketing, with broader nutritional supplement scope.

Others

• Oura: Oura is a women's health-focused smart ring maker that has increasingly targeted perimenopause/menopause monitoring and women's hormonal health features. Adjacent rather than direct: comparable target demographic and growing menopause-health association, but not a supplement/OTC product competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@hellobonafide
• Facebookfacebook.com/hellobonafide
• Instagraminstagram.com/hellobonafide
• TikToktiktok.com/@hellobonafide
• Pinterestpinterest.com/hellobonafide
• Xx.com/hellobonafide

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bonafide Health